Danko Martincic

5.4k total citations
20 papers, 238 citations indexed

About

Danko Martincic is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Danko Martincic has authored 20 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Danko Martincic's work include Multiple Myeloma Research and Treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Danko Martincic is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Danko Martincic collaborates with scholars based in United States, United Kingdom and Germany. Danko Martincic's co-authors include David Gailani, James A. Whitlock, Kenneth R. Hande, Vladimir Kravtsov, Robert K. Fairbanks, Hakan Kaya, Christopher M. Lee, Wayne T. Lamoreaux, Russell E. Ware and Ameer L. Elaimy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Danko Martincic

18 papers receiving 235 citations

Peers

Danko Martincic
Donna Bucci United States
Eugene Nikitin Russia
Elizabeth Hall–Meyers United States
Laurie Catley United States
Christian Hosius Germany
Janet Briel United States
Roberta Gonella Italy
Weiying Gu China
Firoz Ahmad India
Miriam Hobbs United States
Donna Bucci United States
Danko Martincic
Citations per year, relative to Danko Martincic Danko Martincic (= 1×) peers Donna Bucci

Countries citing papers authored by Danko Martincic

Since Specialization
Citations

This map shows the geographic impact of Danko Martincic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danko Martincic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danko Martincic more than expected).

Fields of papers citing papers by Danko Martincic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danko Martincic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danko Martincic. The network helps show where Danko Martincic may publish in the future.

Co-authorship network of co-authors of Danko Martincic

This figure shows the co-authorship network connecting the top 25 collaborators of Danko Martincic. A scholar is included among the top collaborators of Danko Martincic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danko Martincic. Danko Martincic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandana, Sreenivasa R, Ana Ruiz‐Casado, Andrew L. Coveler, et al.. (2025). 2223P First-line (1L) AZD0171 + durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): Phase II study results. Annals of Oncology. 36. S1150–S1151.
2.
3.
Hoffman‐Censits, Jean, Petros Grivas, Thomas Powles, et al.. (2022). 665 JAVELIN Bladder Medley: a phase 2 trial of avelumab in combination with other antitumor drugs as first-line maintenance therapy for advanced urothelial carcinoma. Regular and Young Investigator Award Abstracts. A695–A695. 3 indexed citations
4.
Jones, Guy C., Hakan Kaya, Kenneth G. MacDonald, et al.. (2012). Overall Survival Analysis of Adjuvant Radiation Versus Observation in Stage I Testicular Seminoma. American Journal of Clinical Oncology. 36(5). 500–504. 17 indexed citations
5.
Fleming, Mark T., Guru Sonpavde, Michael Kolodziej, et al.. (2012). Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 10(1). 6–14. 23 indexed citations
6.
Kaya, Hakan, Danko Martincic, Ameer L. Elaimy, et al.. (2011). Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients. International Journal of Hematology. 95(1). 64–70. 34 indexed citations
7.
Fleming, Mark T., Michael Kolodziej, Shivanshu Awasthi, et al.. (2010). Results of a randomized phase II study of mitoxantrone versus mitoxantrone with cetuximab in metastatic castrate-resistant prostate cancer (CRPC) previously treated with docetaxel-based chemotherapy.. Journal of Clinical Oncology. 28(15_suppl). 4555–4555. 2 indexed citations
8.
Tward, Jonathan D., et al.. (2007). Survival outcomes for multiple myeloma over three decades: A Surveillance, Epidemiology, and End Results (SEER) analysis. Journal of Clinical Oncology. 25(18_suppl). 8019–8019. 16 indexed citations
9.
10.
Martincic, Danko & Kenneth R. Hande. (2005). Topoisomerase II inhibitors. 101–121. 20 indexed citations
11.
Hamid, Rizwan, Cindy L. Vnencak‐Jones, Danko Martincic, et al.. (2004). Recurrent Abnormalities in TGIF RNA Sequence in Blasts from Patients with Acute Myeloid Leukemia.. Blood. 104(11). 419–419. 1 indexed citations
12.
Tarumi, Takashi, Danko Martincic, A. Thomas, et al.. (2000). Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome. Blood. 96(3). 1191–1193. 19 indexed citations
13.
Tarumi, Takashi, Danko Martincic, James A. Whitlock, et al.. (2000). Conserved Worldwide Linkage Disequilibrium in the Human Factor XI Gene. Genomics. 70(2). 269–272. 4 indexed citations
14.
Tarumi, Takashi, Danko Martincic, A. Thomas, et al.. (2000). Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome. Blood. 96(3). 1191–1193. 2 indexed citations
15.
Martincic, Danko, et al.. (1999). Detection of mutations by automated fluorescence/RNA-based dideoxy fingerprinting (ARddF). Oncogene. 18(3). 617–621. 3 indexed citations
16.
Martincic, Danko, Vladimir Kravtsov, & David Gailani. (1999). Factor XI Messenger RNA in Human Platelets. Blood. 94(10). 3397–3404. 28 indexed citations
17.
Martincic, Danko, Sherri A. Zimmerman, Russell E. Ware, et al.. (1998). Identification of Mutations and Polymorphisms in the Factor XI Genes of an African American Family by Dideoxyfingerprinting. Blood. 92(9). 3309–3317. 26 indexed citations
18.
Jennings, Mark T., Charles E. Hart, James A. Whitlock, et al.. (1997). Transforming growth factor b as a potential tumor progression factor among hyperdiploid glioblastoma cultures: Evidence for the role of platelet-derived growth factor. Journal of Neuro-Oncology. 31(3). 233–253. 16 indexed citations
19.
Koury, Mark J., Danko Martincic, Donald W. Horne, et al.. (1997). Folate Deficiency Delays the Onset But Increases the Incidence of Leukemia in Friend Virus-Infected Mice. Blood. 90(10). 4054–4061. 9 indexed citations
20.
Martincic, Danko & James A. Whitlock. (1996). Improved detection of p53 point mutations by dideoxyfingerprinting (ddF).. PubMed. 13(9). 2039–44. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Bucci Breakdown of academic impact, for papers by Eugene Nikitin Breakdown of academic impact, for papers by Elizabeth Hall–Meyers Breakdown of academic impact, for papers by Laurie Catley Breakdown of academic impact, for papers by Christian Hosius Breakdown of academic impact, for papers by Janet Briel Breakdown of academic impact, for papers by Roberta Gonella Breakdown of academic impact, for papers by Weiying Gu Breakdown of academic impact, for papers by Firoz Ahmad Breakdown of academic impact, for papers by Miriam Hobbs
Rankless by CCL
2026